Company profile: Alphyn Biologics
1.1 - Company Overview
Company description
- Provider of proprietary drug therapies for skin diseases, including Zabalafin hydrogel (AB-101a), a steroid-free topical for atopic dermatitis targeting immune and bacterial components; the Zabalafin (AB-101) multi-bioactive platform; and AB-101b in development for Epidermolysis Bullosa to address inflammation, itch, pain, and skin infection.
Products and services
- Zabalafin Platform (AB-101 Drug Platform): Multi-compound platform containing multiple bioactive compounds to architect therapeutics that target multiple diseases and symptoms
- Zabalafin hydrogel (AB-101a): Non-steroidal topical hydrogel engineered for atopic dermatitis, targeting the immune system and bacterial components of the disease without steroids
- AB-101b for Epidermolysis Bullosa: In-development drug candidate created to treat EB symptoms including inflammation, itch, and pain, and to fight skin infection
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alphyn Biologics
Tanomed
HQ: Sweden
Website
- Description: Provider of medical product research and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tanomed company profile →
TriPharm
HQ: United States
Website
- Description: Provider of pharmaceuticals as a privately held pharmaceuticals company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriPharm company profile →
Fluoresentric
HQ: United States
Website
- Description: Provider of assay design, optimization, and custom manufacturing services for the healthcare and biotechnology sector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluoresentric company profile →
Calixa Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical drug development focused on a novel cephalosporin to address multi-drug resistant organisms, targeting infections caused by resistant gram-negative bacteria, especially Pseudomonas aeruginosa.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calixa Therapeutics company profile →
Anacor Pharmaceuticals
HQ: United States
Website
- Description: Provider of small-molecule therapeutics based on a boron chemistry platform, focused on developing topical treatments for fungal, bacterial, and inflammatory diseases, including its primary product candidate AN2690, a novel topical antifungal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anacor Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alphyn Biologics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alphyn Biologics
2.2 - Growth funds investing in similar companies to Alphyn Biologics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alphyn Biologics
4.2 - Public trading comparable groups for Alphyn Biologics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →